Jinghua Cao Selected Research

Neoplasms (Cancer)

1/2022	Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
1/2020	Decylubiquinone suppresses breast cancer growth and metastasis by inhibiting angiogenesis via the ROS/p53/ BAI1 signaling pathway.
1/2018	HMGA1 Overexpression is Associated With the Malignant Status and Progression of Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jinghua Cao Research Topics

Disease

5	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2018
4	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
3	Neoplasms (Cancer) 01/2022 - 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Diabetes Mellitus 01/2019
1	Stomach Neoplasms (Stomach Cancer) 08/2016

Drug/Important Bio-Agent (IBA)

1	atrial natriuretic factor receptor AIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Glipizide (Glucotrol)FDA LinkGeneric 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2022
1	FilaminsIBA 01/2020
1	2,3- dimethoxy- 5- methyl- 6- decyl- 1,4- benzoquinoneIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	coenzyme Q10 (CoQ10)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	HMGA ProteinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-3IBA 08/2016